Literature DB >> 9358558

Effect of drug load and plate coating on the particle size distribution of a commercial albuterol metered dose inhaler (MDI) determined using the Andersen and Marple-Miller cascade impactors.

M M Nasr1, D L Ross, N C Miller.   

Abstract

PURPOSE: The purpose of this study is to investigate the effect of drug load, the coating of impactor stages, and the design of cascade impactors on albuterol MDIs particle size distribution measurements. The results of the investigation will be used to explain the "loading effect" recently reported.
METHODS: Particle size distribution parameters of a commercial albuterol MDI were measured using both Andersen (AI) and Marple-Miller (MMI) Cascade Impactors, where plates were either left uncoated or coated with silicone or glycerin. A previously validated HPLC-EC method was used for the assay of albuterol collected by the impactor and in single spray content determinations.
RESULTS: Coating impactor collection plates had an impact on measured MMAD and GSD values for single puff measurements but very little or no effect for the multi puff measurements. Due to particle bounce, the percent of albuterol fine particles deposited in the filter and impactor finer stages (< 1.10 microns in AI and < 1.25 microns in MMI) in uncoated single puff experiments was much higher in comparison to either coated single puff or multi-puff (coated and uncoated) measurements.
CONCLUSIONS: Evaluation of drug load and plate coating are necessary to determine whether observed particle size distributions are representative of the generated aerosol or are the result of particle bounce and reentrainment. In order to minimize particle bounce, especially for single puff determinations, it may be useful to apply a thin layer of a sticky coating agent to the surfaces of impactor plates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358558     DOI: 10.1023/a:1012180924063

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  The influence of sampling chamber dimensions on aerosol particle size measurement by cascade impactor and twin impinger.

Authors:  K Fults; T D Cyr; A J Hickey
Journal:  J Pharm Pharmacol       Date:  1991-10       Impact factor: 3.765

2.  Low first-spray drug content in albuterol metered-dose inhalers.

Authors:  T D Cyr; S J Graham; K Y Li; E G Lovering
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

Review 3.  Regulatory aspects of modifications to innovator bronchodilator metered dose inhalers and development of generic substitutes.

Authors:  W P Adams; G Poochikian; A S Taylor; R M Patel; G P Burke; R L Williams
Journal:  J Aerosol Med       Date:  1994

4.  Particle size distribution of single and multiple sprays of salbutamol metered-dose inhalers (MDIs).

Authors:  S J Graham; R C Lawrence; E D Ormsby; R K Pike
Journal:  Pharm Res       Date:  1995-09       Impact factor: 4.200

5.  Single-puff particle-size analysis of albuterol metered-dose inhalers (MDIs) by high-pressure liquid chromatography with electrochemical detection (HPLC-EC).

Authors:  M M Nasr
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

6.  Size aspects of metered-dose inhaler aerosols.

Authors:  C S Kim; D Trujillo; M A Sackner
Journal:  Am Rev Respir Dis       Date:  1985-07

7.  Distortion of cascade impactor measured size distribution due to bounce and blow-off.

Authors:  N A Esmen; T C Lee
Journal:  Am Ind Hyg Assoc J       Date:  1980-06

8.  Loading effect on particle size measurements by inertial sampling of albuterol metered dose inhalers.

Authors:  M M Nasr; J F Allgire
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

  8 in total
  4 in total

1.  The abbreviated impactor measurement (AIM) concept: part 1--Influence of particle bounce and re-entrainment-evaluation with a "dry" pressurized metered dose inhaler (pMDI)-based formulation.

Authors:  J P Mitchell; M W Nagel; V Avvakoumova; H MacKay; R Ali
Journal:  AAPS PharmSciTech       Date:  2009-03-12       Impact factor: 3.246

2.  The abbreviated impactor measurement (AIM) concept: part II--Influence of evaporation of a volatile component-evaluation with a "droplet-producing" pressurized metered dose inhaler (pMDI)-based formulation containing ethanol as cosolvent.

Authors:  J P Mitchell; M W Nagel; V Avvakoumova; H MacKay; R Ali
Journal:  AAPS PharmSciTech       Date:  2009-03-17       Impact factor: 3.246

Review 3.  Minimizing variability of cascade impaction measurements in inhalers and nebulizers.

Authors:  Matthew Bonam; David Christopher; David Cipolla; Brent Donovan; David Goodwin; Susan Holmes; Svetlana Lyapustina; Jolyon Mitchell; Steve Nichols; Gunilla Pettersson; Chris Quale; Nagaraja Rao; Dilraj Singh; Terrence Tougas; Mike Van Oort; Bernd Walther; Bruce Wyka
Journal:  AAPS PharmSciTech       Date:  2008-02-28       Impact factor: 3.246

4.  Glycoside scutellarin enhanced CD-MOF anchoring for laryngeal delivery.

Authors:  Kena Zhao; Tao Guo; Caifen Wang; Yong Zhou; Ting Xiong; Li Wu; Xue Li; Priyanka Mittal; Senlin Shi; Ruxandra Gref; Jiwen Zhang
Journal:  Acta Pharm Sin B       Date:  2020-05-07       Impact factor: 11.413

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.